deflazacort has been researched along with aprepitant in 1 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (aprepitant) | Trials (aprepitant) | Recent Studies (post-2010) (aprepitant) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 769 | 229 | 521 |
| Protein | Taxonomy | deflazacort (IC50) | aprepitant (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
| Substance-P receptor | Homo sapiens (human) | 0.0002 | |
| Substance-P receptor | Meriones unguiculatus (Mongolian gerbil) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alweshahy, S; Elshabasy, DA; Tantawy, MA; Youssef, NF | 1 |
1 other study(ies) available for deflazacort and aprepitant
| Article | Year |
|---|---|
Simultaneous Determination of Co-administrated Deflazacort, Aprepitant and Granisetron in Dosage Forms and Spiked Human Plasma by RP-HPLC/PAD.
Topics: Aprepitant; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Granisetron; Humans; Limit of Detection; Linear Models; Pregnenediones; Reproducibility of Results | 2019 |